Accueil>>Signaling Pathways>> Tyrosine Kinase>> IGF1R>>Xentuzumab

Xentuzumab (Synonyms: BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody)

Catalog No.GC70151

Xentuzumab (anticorps recombinant anti-IGF1 et IGF2 humains ; BI836845) est un anticorps monoclonal humanisé ciblant les ligands IGF1 et IGF2 de l'IGF. Xentuzumab inhibe les signaux de croissance stimulants d'IGF1 et d'IGF2, ainsi que l'activation d'AKT.

Products are for research use only. Not for human use. We do not sell to patients.

Xentuzumab Chemical Structure

Cas No.: 1417158-65-6

Taille Prix Stock Qté
1mg
315,00 $US
En stock
5mg
855,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Avis

Review for Xentuzumab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Xentuzumab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.